Pregnancy Specific β1-glycoprotein in Threatened Abortion

This publication has 15 references indexed in Scilit:

• SPECIFIC AND SENSITIVE DETERMINATION OF PREGNANCY-SPECIFIC β1-GLYCOPROTEIN BY RADIOIMMUNOASSAY
  The Lancet, 1977
• CONCENTRATIONS OF PREGNANCY-SPECIFIC β1-GLYCOPROTEIN IN MATERNAL BLOOD IN NORMAL PREGNANCY AND IN INTRAUTERINE GROWTH RETARDATION
  The Lancet, 1977
• Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues.
  Journal of Clinical Pathology, 1977
• Pregnancy specificβ 1 — a product of the syncytiotrophoblast
  Cellular and Molecular Life Sciences, 1976
• HCG, HPL, OESTRADIOL, PROGESTERONE AND AFP IN SERUM IN PATIENTS WITH THREATENED ABORTION
  BJOG: An International Journal of Obstetrics and Gynaecology, 1976
• Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein
  American Journal of Obstetrics and Gynecology, 1975
• Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin
  American Journal of Obstetrics and Gynecology, 1973
• HUMAN CHORIONIC SOMATOMAMMOTROPIN (HCS) PLASMA LEVELS IN NORMAL AND PATHOLOGICAL PREGNANCIES AND THEIR CORRELATION WITH THE PLACENTAL FUNCTION
  Acta Endocrinologica, 1972
• Placental Lactogen Levels as Guide to Outcome of Threatened Abortion
  BMJ, 1972
• Nachweis und Charakterisierung von Schwangerschaftsproteinen in der menschlichen Placenta, sowie ihre quantitative immunologische Bestimmung im Serum schwangerer Frauen
  Archiv für Gynäkologie, 1971